136 related articles for article (PubMed ID: 21244753)
81. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129
[TBL] [Abstract][Full Text] [Related]
82. The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation.
Schnegg CI; Greene-Schloesser D; Kooshki M; Payne VS; Hsu FC; Robbins ME
Free Radic Biol Med; 2013 Aug; 61():1-9. PubMed ID: 23499837
[TBL] [Abstract][Full Text] [Related]
83. Role of endoplasmic reticulum stress in the protective effects of PPARβ/δ activation on endothelial dysfunction induced by plasma from patients with lupus.
Toral M; Jiménez R; Romero M; Robles-Vera I; Sánchez M; Salaices M; Sabio JM; Duarte J
Arthritis Res Ther; 2017 Dec; 19(1):268. PubMed ID: 29208022
[TBL] [Abstract][Full Text] [Related]
84. PPAR-δ Activation Ameliorates Diabetes-Induced Cognitive Dysfunction by Modulating Integrin-linked Kinase and AMPA Receptor Function.
Abdel-Rahman EA; Bhattacharya S; Buabeid M; Majrashi M; Bloemer J; Tao YX; Dhanasekaran M; Escobar M; Amin R; Suppiramaniam V
J Am Coll Nutr; 2019; 38(8):693-702. PubMed ID: 31008686
[TBL] [Abstract][Full Text] [Related]
85. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
[TBL] [Abstract][Full Text] [Related]
86. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
87. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
[TBL] [Abstract][Full Text] [Related]
88. BCL-6: a possible missing link for anti-inflammatory PPAR-delta signalling in pancreatic beta cells.
Kharroubi I; Lee CH; Hekerman P; Darville MI; Evans RM; Eizirik DL; Cnop M
Diabetologia; 2006 Oct; 49(10):2350-8. PubMed ID: 16896941
[TBL] [Abstract][Full Text] [Related]
89. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) activates promyogenic signaling pathways, thereby promoting myoblast differentiation.
Lee SJ; Go GY; Yoo M; Kim YK; Seo DW; Kang JS; Bae GU
Biochem Biophys Res Commun; 2016 Jan; 470(1):157-162. PubMed ID: 26768366
[TBL] [Abstract][Full Text] [Related]
90. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
[TBL] [Abstract][Full Text] [Related]
91. Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
Jové M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2005 May; 1734(1):52-61. PubMed ID: 15866483
[TBL] [Abstract][Full Text] [Related]
92. Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells.
Fan Y; Wang Y; Tang Z; Zhang H; Qin X; Zhu Y; Guan Y; Wang X; Staels B; Chien S; Wang N
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):315-21. PubMed ID: 18048767
[TBL] [Abstract][Full Text] [Related]
93. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
94. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.
Zarzuelo MJ; Gómez-Guzmán M; Jiménez R; Quintela AM; Romero M; Sánchez M; Zarzuelo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Cardiovasc Res; 2013 Sep; 99(4):622-31. PubMed ID: 23752977
[TBL] [Abstract][Full Text] [Related]
95. Differential actions of PPAR-α and PPAR-β/δ on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice.
Rachid TL; Silva-Veiga FM; Graus-Nunes F; Bringhenti I; Mandarim-de-Lacerda CA; Souza-Mello V
PLoS One; 2018; 13(1):e0191365. PubMed ID: 29351550
[TBL] [Abstract][Full Text] [Related]
96. Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding.
Schwarz R; Tänzler D; Ihling CH; Sinz A
PLoS One; 2016; 11(3):e0151412. PubMed ID: 26992147
[TBL] [Abstract][Full Text] [Related]
97. Transcriptional regulation of Δ6-desaturase by peroxisome proliferative-activated receptor δ agonist in human pancreatic cancer cells: role of MEK/ERK1/2 pathway.
Darabi M; Byagowi S; Fayezi S; Darabi M; Mirshahvaladi S; Sahmani M
ScientificWorldJournal; 2013; 2013():607524. PubMed ID: 24294133
[TBL] [Abstract][Full Text] [Related]
98. Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine.
Sobolevsky T; Dikunets M; Sukhanova I; Virus E; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):754-60. PubMed ID: 22977012
[TBL] [Abstract][Full Text] [Related]
99. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
[TBL] [Abstract][Full Text] [Related]
100. Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.
Niu HS; Ku PM; Niu CS; Cheng JT; Lee KS
Drug Des Devel Ther; 2015; 9():5625-32. PubMed ID: 26508837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
